"This agreement between the US and the UK is good news for patients who need access to innovative technologies and medicines. It will also support the development of a strong life sciences sector in the UK and help drive economic growth in the country.
This is a good step forward that recognizes the value of innovation for patients, and we look forward to building on it.
We will continue to work collaboratively with the UK government to build the life sciences sector in the country and ensure patients can access our innovative medicines".